Yanjun Su

Learn More
PURPOSE This study assessed the nutritional status of elderly Chinese lung cancer inpatients using a revised version of the Mini-Nutritional Assessment (MNA(®)) tool. PATIENTS AND METHODS The revised version of the MNA tool was used to assess the nutritional status of 180 elderly Chinese lung cancer inpatients prior to their scheduled surgery between June(More)
The SARI (suppressor of AP-1, regulated by IFN) gene, which is also called BATF2, is associated with the risk of several kinds of cancer, and loss of SARI expression is frequently detected in aggressive and metastatic cancer. However, the functional role of SARI in lung adenocarcinoma remains unknown. We have shown that loss of SARI expression initiates(More)
BACKGROUND The subtypes of NSCLC have unique characteristics of pathogenic mechanism and responses to targeted therapies. Thus, non-invasive markers for diagnosis of different subtypes of NSCLC at early stage are needed. RESULTS Based on the results from the screening and validation process, 3 miRNAs (miR-532, miR-628-3p and miR-425-3p) were found to(More)
The Shuttle Radar Topography Mission (SRTM) digital elevation model (DEM) is one of the most complete and frequently used global-scale DEM products in various applications. However, previous studies have shown that the SRTM DEM is systematically higher than the actual land surface in vegetated mountain areas. The objective of this study is to propose a(More)
As a large carbon pool, global forest ecosystems are a critical component of the global carbon cycle. Accurate estimations of global forest aboveground biomass (AGB) can improve the understanding of global carbon dynamics and help to quantify anthropogenic carbon emissions. Light detection and ranging (LiDAR) techniques have been proven that can accurately(More)
To compare survival of patients with non-small cell lung cancer (NSCLC) who underwent surgical resection and lymph node sampling based on guidelines proposed by the American College of Surgeons Oncology Group (ACOSOG), National Comprehensive Cancer Network (NCCN), the OSI Pharmaceutical RADIANT trial, and the International Association for the Study of Lung(More)
  • 1